| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |